Rituximab and the risk of transformation of follicular lymphoma: a retrospective pooled analysisMassimo Federico, Bertrand Coiffier, Vittoria Tarantino et al.|The Lancet Haematology|2018Cited by 116
Trends in incidence, treatment and survival of aggressive B-cell lymphoma in the Netherlands 1989-2010Djamila E. Issa, O. Visser, Peter C. Huijgens et al.|Haematologica|2014Cited by 57
Fixed-duration venetoclax plus obinutuzumab improves quality of life and geriatric impairments in FCR-unfit patients with CLLLina van der Straten, Mark‐David Levin, Johan A. Dobber et al.|Blood|2023Cited by 27